Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any glycogen storage disease in which the cause of the disease is a mutation in the PHKA2 gene, with no PHK in liver, but normal activity in erythrocytes.
1 clinical trial registered, 1 recruiting. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
3 publications have been identified in PubMed for glycogen storage disease IXa2. Research spans Epidemiology / Natural History (67%) and Case Report / Case Series (33%).
Zhang Q (2025). [PMID: 39396772](https://pubmed.ncbi.nlm.nih.gov/39396772/). *The Canadian journal of cardiology*. [Case Report / Case Series]
El-Karaksy H (2025). [PMID: 41165782](https://pubmed.ncbi.nlm.nih.gov/41165782/). *Human genetics*. [Epidemiology / Natural History]
Geramizadeh B (2024). [PMID: 39707443](https://pubmed.ncbi.nlm.nih.gov/39707443/). *Orphanet journal of rare diseases*. [Epidemiology / Natural History]
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 6:54 PM UTC